Carfilzomib

Item number	Size	Manual	Delivery time	Price
LKT-C0271.1	1 mg	-	3 - 8 business days*	139.00€
LKT-C0271.5	5 mg	-	3 - 8 business days*	268.00€
LKT-C0271.25	25 mg	-	3 - 8 business days*	784.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Carfilzomib, a tetrapeptide epoxyketone, is an epoxomicin derivate with potential antineoplastic... more

Close menu

Product information "Carfilzomib"

Carfilzomib, a tetrapeptide epoxyketone, is an epoxomicin derivate with potential antineoplastic activity. Carfilzomib irreversibly binds to and inhibits the chymotrypsin-like activity of the 20S proteasome, an enzyme responsible for degrading a large variety of cellular proteins.

Keywords:	PR-171, (S)-4-methyl-N-((S)-1-((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-ylamino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide
Supplier:	LKT Laboratories
Supplier-Nr:	C0271

Properties

Application:	Proteasome chymotrypsin-like activity inhibitor
MW:	719.91 D
Formula:	C40H57N5O7

Database Information

CAS :	868540-17-4\| Matching products
KEGG ID :	K02737 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	-20°C (International: -20°C)
Signal Word:	Danger
GHS Hazard Pictograms:
H Phrases:	H315, H319, H361, H372
P Phrases:	P201, P202, P260, P261, P264, P270, P280, P281, P314, P321, P362, P302+P352, P308+P313, P332+P313, P405, P501